Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1981-08-13
1982-05-25
Breitenstein, G. T.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
424319, 560 37, 562442, A61K 3124, C07C101447, C07C101453
Patent
active
043316832
ABSTRACT:
The compounds of the invention are certain new propenamides and 2-butenamides having a (carboxyalkanamido)phenyl or a (carboxyalkenamido)phenyl group at the 3-position, and certain esters thereof, and certain cyclopropanecarboxamide compounds having a (carboxyalkanamido)phenyl group or a (carboxyalkenamido)phenyl group at the 2-position, and certain esters thereof. The compounds are useful for antagonizing the spasmogenic activity of slow-reacting substance of anaphylaxis (SRS-A) in a human subject. In particular, the compounds of the invention are useful for preventing and treating certain obstructive airways diseases, notably allergic bronchial asthma, allergic rhinitis and certain skin disorders, in human subjects.
REFERENCES:
patent: 3966965 (1976-06-01), Sellstedt et al.
Breitenstein G. T.
Frost Albert E.
Knuth Charles J.
Lumb J. Trevor
Pfizer Inc.
LandOfFree
Carboxamide compounds as SRS-A antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Carboxamide compounds as SRS-A antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Carboxamide compounds as SRS-A antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2076865